Literature DB >> 2032734

Production of an hybridoma library to recombinant porcine alpha I interferon: a very sensitive assay (ISBBA) allows the detection of a large number of clones.

R M L'Haridon1, P Bourget, F Lefevre, C La Bonnardiere.   

Abstract

The preparation of a panel of hybridoma cell lines secreting monoclonal antibodies (MAbs) specific for Recombinant Porcine Alpha I Interferon is reported. Of these MAbs, 28 were subcloned and 21 secreted their antibody during several months. They were partially characterized for their ability to bind and neutralize Alpha Interferons (IFNs-alpha) from different animal species. All the clones bound Recombinant Porcine IFN-alpha 1, 8 bound Human leukocyte IFN, and one bound recombinant Human IFN-alpha 2b, but not IFN-alpha 2a. Two screening procedures were used for the detection of specific MAbs: neutralization assay and immunosorbent binding bioassay. This last method appears to be simple and very sensitive since it permits to detect 100 pg/ml MAb. In addition it can detect weakly, as well as strongly neutralizing antibodies. Probable mechanisms involved in this assay, and possible applications of this method for IFNs-alpha subtyping are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032734     DOI: 10.1089/hyb.1991.10.35

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  9 in total

1.  Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.

Authors:  Elida M Bautista; Geoffrey S Ferman; Douglas Gregg; Mario C S Brum; Marvin J Grubman; William T Golde
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  The Pseudorabies Virus Glycoprotein gE/gI Complex Suppresses Type I Interferon Production by Plasmacytoid Dendritic Cells.

Authors:  Jochen A S Lamote; Manon Kestens; Cliff Van Waesberghe; Jonas Delva; Steffi De Pelsmaeker; Bert Devriendt; Herman W Favoreel
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

3.  The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.

Authors:  Jonas L Delva; Cliff Van Waesberghe; Wim Van Den Broeck; Jochen A Lamote; Nick Vereecke; Sebastiaan Theuns; Liesbeth Couck; Herman W Favoreel
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

4.  Production and characterization of monoclonal antibodies directed against Eimeria falciformis and cross-reactive with sporozoites from two species of avian coccidia.

Authors:  M Kazanji; A Rhalem; P Péry
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  Alphaherpesvirus-induced activation of plasmacytoid dendritic cells depends on the viral glycoprotein gD and is inhibited by non-infectious light particles.

Authors:  Jonas L Delva; Cliff Van Waesberghe; Barbara G Klupp; Thomas C Mettenleiter; Herman W Favoreel
Journal:  PLoS Pathog       Date:  2021-11-29       Impact factor: 6.823

6.  Interferon-alpha production and tissue localization of interferon-alpha/beta producing cells after intradermal administration of Aujeszky's disease virus-infected cells in pigs.

Authors:  K Artursson; M Lindersson; N Varela; A Scheynius; G V Alm
Journal:  Scand J Immunol       Date:  1995-02       Impact factor: 3.487

7.  TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions.

Authors:  M Godet; R L'Haridon; J F Vautherot; H Laude
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

8.  Enrichment of coronavirus-induced interferon-producing blood leukocytes increases the interferon yield per cell: a study with pig leukocytes.

Authors:  W Nowacki; B Charley
Journal:  Res Immunol       Date:  1993-02

9.  Age-related increase of porcine natural interferon alpha producing cell frequency and of interferon yield per cell.

Authors:  W Nowacki; B Cederblad; C Renard; C La Bonnardière; B Charley
Journal:  Vet Immunol Immunopathol       Date:  1993-07       Impact factor: 2.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.